Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform

Chimeric antigen receptor (CAR)-modified T-cell adoptive immunotherapy is a remarkable therapeutic option proven effective in the treatment of hematological malignancies. In order to optimize cell manufacturing, we sought to develop a novel clinical-grade protocol to obtain CAR-modified cytokine-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnani, Chiara F., Turazzi, Nice, Benedicenti, Fabrizio, Calabria, Andrea, Tenderini, Erika, Tettamanti, Sarah, Attianese, Greta M.P. Giordano, Cooper, Laurence J.N., Aiuti, Alessandro, Montini, Eugenio, Biondi, Andrea, Biagi, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239498/
https://www.ncbi.nlm.nih.gov/pubmed/27323395
http://dx.doi.org/10.18632/oncotarget.9955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239498/
https://www.ncbi.nlm.nih.gov/pubmed/27323395
http://dx.doi.org/10.18632/oncotarget.9955

Ejemplares similares